MADRIGAL PHARMACEUTICALS, INC.
Public company- Headquarters
- WEST CONSHOHOCKEN, Pennsylvania
- Ticker
- MDGL
- CIK
- 0001157601
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
1
1 appointment, 0 departures
Last event
Aug 12, 2026
Executive appointmentClass II director appointed: John C. Reed, M.D., Ph.D.
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Class II directorJohn C. Reed, M.D., Ph.D. | Aug 12, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Merck & Co., Inc.
WARN notice: Rahway, NJ
- NOVO NORDISK A S
WARN notice: Plainsboro, NJ
- Executive appointment
Class II director appointed: John C. Reed, M.D., Ph.D.
John C. Reed, M.D., Ph.D. was named Class II director of MADRIGAL PHARMACEUTICALS, INC., effective August 11, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 12, 2026Role: Class II director
Only one public record so far. We add events as soon as a new filing lands; watch MADRIGAL PHARMACEUTICALS, INC. to get them in your digest.
Last verified Nov 8, 2026